TP53 and Machado-Joseph disease: Consistently with these findings, and although global TP53 levels are similar in patients and healthy controls, our follow-up analysis of blood samples from 18 MJD patients collected at distinct moments of disease progression over a maximum period of nine years showed that the abundance of pro-apoptotic TP53 transcripts increases with disease progression.